These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The clinical care of adult patients with sickle cell disease. Olujohungbe A; Howard J Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260 [TBL] [Abstract][Full Text] [Related]
5. Life-threatening complications of sickle cell disease in children. Mills ML JAMA; 1985 Sep; 254(11):1487-91. PubMed ID: 4032653 [No Abstract] [Full Text] [Related]
6. Expanding the role of hydroxyurea in children with sickle cell disease. Rogers ZR; Buchanan GR J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174 [No Abstract] [Full Text] [Related]
8. Current and emerging treatments for sickle cell disease. Monus T; Howell CM JAAPA; 2019 Sep; 32(9):1-5. PubMed ID: 31460979 [TBL] [Abstract][Full Text] [Related]
9. Management of Sickle Cell Disease in Children. Noronha SA; Sadreameli SC; Strouse JJ South Med J; 2016 Sep; 109(9):495-502. PubMed ID: 27598348 [TBL] [Abstract][Full Text] [Related]
10. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years. Chaturvedi S; DeBaun MR Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630 [TBL] [Abstract][Full Text] [Related]
11. Current management of sickle cell anemia. McGann PT; Nero AC; Ware RE Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23709685 [TBL] [Abstract][Full Text] [Related]
12. Sickle cell anemia and related hemoglobinopathies. Vichinsky EP; Lubin BH Pediatr Clin North Am; 1980 May; 27(2):429-47. PubMed ID: 6155657 [TBL] [Abstract][Full Text] [Related]
13. Advances in management of sickle cell disease. Agarwal MB Indian J Pediatr; 2003 Aug; 70(8):649-54. PubMed ID: 14510086 [TBL] [Abstract][Full Text] [Related]
14. Managing acute chest syndrome of sickle cell disease in an African setting. Fawibe AE Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):526-31. PubMed ID: 18455745 [TBL] [Abstract][Full Text] [Related]
15. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria. Adegoke SA; Adeodu OO; Adekile AD Niger J Clin Pract; 2015; 18(1):95-101. PubMed ID: 25511352 [TBL] [Abstract][Full Text] [Related]
16. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503 [TBL] [Abstract][Full Text] [Related]
17. Recognising and managing sickle cell crisis in the emergency department. O'Conor CE Ir Med J; 2003 Sep; 96(8):229-30. PubMed ID: 14653372 [No Abstract] [Full Text] [Related]
18. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea. Tripathi A; Jerrell JM; Stallworth JR Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765 [TBL] [Abstract][Full Text] [Related]
19. Sickle cell disease in North Europe. Howard J; Davies SC Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983 [TBL] [Abstract][Full Text] [Related]
20. Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era. Hankins JS; Penkert RR; Lavoie P; Tang L; Sun Y; Hurwitz JL Exp Biol Med (Maywood); 2016 Apr; 241(7):749-54. PubMed ID: 26940953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]